Home Tags Alcinous Pharmaceuticals

Tag: Alcinous Pharmaceuticals

Commerce board approves 3 innovation vouchers, tax incentives

PROVIDENCE – The R.I. Commerce Corp. board of directors voted to approve three innovation vouchers Tuesday evening, each for a value of $50,000.The award...
TEAM MEETING: From left, Brenton DeBoef, professor of chemistry at the University of Rhode Island, and Alcinous Pharmaceutical team members Nicholas DaSilva, CEO and Ph.D. student in the URI College of Pharmacy; Benjamin Barlock, chief technology officer and Ph.D. student in the URI College of Pharmacy; David Worthen, chief operations officer and URI assistant professor in the Department of Biomedical and Pharmaceutical Sciences and the Department of Chemical Engineering; and Ken Rose, chief scientific officer and Ph.D. student in the URI College of Pharmacy, discuss Alcinous’ latest research project. / PBN PHOTO/RUPERT WHITELEY

Alcinous to use $50K Innovation Voucher to create new PARP inhibitor

Five weeks prior to celebrating its first year in business, Alcinous Pharmaceuticals received a $50,000 Innovation Voucher from R.I. Commerce Corp.The microcompany had been...
THE R.I. COMMERCE CORP. board of directors approved two new Qualified Jobs tax credits to bring two Massachusetts companies to Rhode Island as well as three new Innovation Vouchers for local company research and development. Above, R.I. Secretary of Commerce Stefan Pryor. / COURTESY R.I. COMMERCE CORP.

Commerce approves new tax incentives, innovation vouchers

PROVIDENCE -  Gov. Gina M. Raimondo and the board of directors for the R.I. Commerce Corp. approved Qualified Jobs tax credits as relocation incentives...
INSPIRED: From left, Nicholas DaSilva, Benjamin Barlock and Kenneth Rose, Ph.D. students at the University of Rhode Island’s College of Pharmacy, discuss the drug-development company they launched, Alcinous Pharmaceuticals. / COURTESY URI/NORA LEWIS

Campus business in drug research

Fed up with the “status quo” in the pharmaceutical industry and inspired by the “endless possibilities” in drug development, current University of Rhode Island...
FROM LEFT, Nicholas DaSilva, Kenneth Rose and Benjamin Barlock, doctoral students at the University of Rhode Island’s College of Pharmacy, which is part of the Academic Health Collaborative, launched a drug development company, Alcinous. They discuss their venture in the pharmacy building on the Kingston Campus in early June. /COURTESY NORA LEWIS

URI graduate students launch pharmaceutical company

SOUTH KINGSTOWN – Three doctoral students at the University of Rhode Island’s College of Pharmacy have started a company that harnesses big data in a...
- Featured Event -

Latest News